Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide exposure and ABCG2 rs2231142 mutation in multiple sclerosis
CTR20200025Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Started Feb 2020; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on CTR20200025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200025.